Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponsegromab in Heart Failure (GARDEN TIMI 74)
NCT05492500Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Sep 2022
- Primary completion
- Mar 2025
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 11
01
Overview
A Phase 2 trial of ponsegromab in heart failure (HF), sponsored by Pfizer. Started Sep 2022; status: terminated.
02
Drugs
ponsegromab
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05492500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05492500.